Your browser doesn't support javascript.
loading
Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
Pasquier, Florence; Sadowsky, Carl; Holstein, Ann; Leterme, Ghislaine Le Prince; Peng, Yahong; Jackson, Nicholas; Fox, Nick C; Ketter, Nzeera; Liu, Enchi; Ryan, J Michael.
Afiliação
  • Pasquier F; Inserm U1171, Memory clinic of CHU and University of Lille, Lille, France.
  • Sadowsky C; Premiere Research Institute, Palm Beach Neurology, Nova SE University, West Palm Beach, FL, USA.
  • Holstein A; Pfizer Vaccine R&D, Collegeville, PA, USA.
  • Leterme Gle P; Pfizer Global Research and Development, Paris cedex 14 - France.
  • Peng Y; Pfizer Vaccine R&D, Collegeville, PA, USA.
  • Jackson N; Pfizer Vaccine R&D, Collegeville, PA, USA.
  • Fox NC; Dementia Research Centre, Department of Neurodegeneration, UCL Institute of Neurology, London, UK.
  • Ketter N; Janssen Research and Development, San Diego, CA, USA.
  • Liu E; Janssen Research and Development, San Diego, CA, USA.
  • Ryan JM; Pfizer Vaccine R&D, Collegeville, PA, USA.
J Alzheimers Dis ; 51(4): 1131-43, 2016.
Article em En | MEDLINE | ID: mdl-26967206

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saponinas / Antipsicóticos / Proteínas Recombinantes de Fusão / Adjuvantes Imunológicos / Doença de Alzheimer Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saponinas / Antipsicóticos / Proteínas Recombinantes de Fusão / Adjuvantes Imunológicos / Doença de Alzheimer Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article